Respiratory Care Practitioner
New York Presbyterian Hospital
New York
Javier Amador-Castaneda, BHS, RRT, FCCM, serves as a luminary in the realm of respiratory care, holding the dual roles of CEO and founder of the Interprofessional Critical Care Network (ICCN) and Lead Respiratory Care Practitioner in the Medical Intensive Care Unit at Columbia University Irving Medical Center. With a career foundation established at the Hospital of the University of Pennsylvania, he brings a wealth of expertise and an unwavering commitment to excellence as a Respiratory Care Practitioner.
Mr. Amador-Castaneda's academic journey is marked by distinction, having graduated with honors from Gwynedd Mercy University in Gwynedd Valley, PA, where he specialized in Respiratory Care within the Health Sciences domain. His resilience and dedication extend beyond academia, evidenced by his 15-year tenure with the United States Army, where he honorably served and retired as a combat veteran.
His fervor for critical care has propelled him to specialize in adult critical care, mechanical ventilation, and non-invasive ventilation. This passion is further manifested in his active participation in numerous prestigious organizations. He has served on several committees within the Society of Critical Care Medicine, including the ICU Liberation Committee, the Program Committee, the Future of Critical Care Taskforce, and the Respiratory Research Section. As an esteemed educator, Mr. Amador-Castaneda has lectured nationally, thereby amplifying his influence and expertise in the field. His scholarly contributions include authoring a book chapter for SCCM's Fundamentals of Critical Care Support, focusing on "Respiratory Support in ARDS: From HFNC to Considerations for Transplant."
As the driving force behind ICCN, Javier Amador-Castaneda continues to inspire, lead, and advocate for groundbreaking advancements in healthcare. His career embodies a legacy of service, knowledge, and innovation, setting a benchmark for excellence in critical care.
Respiratory Support in ARDS: From HFNC to Consideration for Transplant
Saturday, January 20, 2024
1:25 PM – 1:55 PM MT
Panel 3 Discussion and Questions
Saturday, January 20, 2024
2:35 PM – 3:00 PM MT